T. V. Serebrovskaya, R. J. Swanson and E. E. Kolesnikova, “Intermittent Hypoxia: Mechanisms of Action and Some Applications to Bronchial Asthma Treatment,” Journal of Physiology and Pharmacology, Vol. 54, No. Suppl. 1, 2003, pp. S35-S41.
 N. R. Prabhakar and G. K. Kumar, “Oxidative Stress in the Systemic and Cellular Responses to Intermittent Hypoxia,” Biological Chemistry, Vol. 385, No. 3-4, 2004, pp. 217-221. http://dx.doi.org/10.1515/BC.2004.015
 B. W. Row, L. Kheirandish, J. J. Neville and D. Gozal, “Impaired Spatial Learning and Hyperactivity in Developing Rats Exposed to Intermittent Hypoxia,” Pediatric Research, Vol. 52, No. 3, 2002, pp. 449-453.
 Z. Cai, D. J. Manalo, G. Wei, E. R. Rodriguez, K. FoxTalbot, J. L. Lu, H. Zweier and G. L. Semenza, “Hearts from Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected against Ischemia-Reperfusion Injury,” Circulation, Vol. 108, No. 1, 2003, pp. 79-85.
 J. C. LaManna, J. C. Chavez and P. Pichiule, “Structural and Functional Adaptation to Hypoxia in the Rat Brain,” Journal of Experimental Biology, Vol. 207, No. 18, 2004, pp. 3163-3169. http://dx.doi.org/10.1242/jeb.00976
 L. D. Lukyanova, “Novel Approach to Understanding of Molecular Mechanisms of Adaptation to Hypoxia,” In: A. Hargens, N. Takeda and P. K. Singal, Eds., Adaptation Biology and Medicine, New Deli, Vol. 4, 2005, pp. 1-19.
 M. Burtscher, O. Pachinger, I. Ehrenbourg, G. Mitterbauer, M. Faulhaber, R. Pühringer and E. Tkatchouk, “Intermittent Hypoxia Increases Exercise Tolerance in Elderly Men with and without Coronary Artery Disease,” International Journal of Cardiology, Vol. 96, No. 2, 2004, pp. 247-254. http://dx.doi.org/10.1016/j.ijcard.2003.07.021
 T. D. Sabdanbekov, “Effect of Hypoxic Training on Clinico-Hemodynamic Indices and Physical Work Capacity of Patients with Large-Focus Myocardial Infarct,” Kardiologiia, Vol. 27, No. 12, 1987, pp. 59-62.
 O. M. Andriankaja, R. J. Genco, J. Dorn, J. Dmochowski, K. Hovey, K. L. Falkner and M. Trevisan, “Periodontal Disease and Risk of Myocardial Infarction: The Role of Gender and Smoking,” European Journal of Epidemiology, Vol. 22, No. 10, 2007, pp. 699-705.
 F. Cairo, S. Castellani, A. M. Gori, M. Nieri, G. Baldelli, R. Abbate and G. P. Pini-Prato, “Severe Periodontitis in Young Adults Is Associated with Sub-Clinical Atherosclerosis,” Journal of Clinical of Periodontology, Vol. 35, No. 6, 2008, pp. 465-472.
 L. L. Humphrey, R. Fu, D. I. Buckley, M. Freeman and M. Helfand, “Periodontal Disease and Coronary Heart Disease Incidence: A Systematic Review and Meta-Analysis,” Journal of General Internal Medicine, Vol. 23, No. 12, 2008, pp. 2079-2086.
 M. Segovia, S. Ganzinelli, S. Reina, E. Borda and L. Sterin-Borda, “Role of Anti-β1 Adrenergic Antibodies from Patients with Periodontitis in Cardiac Dysfunction,” Journal of Oral Patholology & Medicine, Vol. 41, No. 3, 2012, pp. 242-248.
 M. Segovia, S. Reina, E. Borda and L. Sterin-Borda, “Autoantibodies to the β1-Adrenoceptor from Patients with Periodontitis as a Risk Factor for Cardiac Dysfunction,” International Scholarly Research Network Dentistry, 2011, Article ID: 791393.
 M. Goppelt-Struebe, “Regulation of Prostaglandin Endoperoxide Synthase (Cyclooxygenase) Isozyme Expression,” Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 52, No. 6, 1995, pp. 213-222.
 W. L. Smith, and R. Langenbach, “Why There Are Two Cyclooxygenase Isozymes,” Journal Clinical Investigation, Vol. 107, No. 6, 2001, pp. 1491-1495.
 S. Gottlieb, “COX 2 Inhibitors May Increase Risk of Heart Attack,” British Medical Journal, Vol. 323, No. 7311, 2001, pp. 471-472.
 K. H. Pitkala, T. E. Strandberg and R. S. Tilvis, “Worsening Heart Failure Associated with COX-2 Inhibitors,” American Journal of Medicine, Vol. 112, No. 5, 2002, pp. 424-426.
 K. Shinmura, X. L. Tang, Y. Wang, Y. T. Xuan, S. Q. Liu, H. Takano, A. Bhatnagar and R. Bolli, “Cyclooxygenase-2 Mediates the Cardioprotective Effects of the Late Phase of Ischemic Preconditioning in Conscious Rabbits,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 18, 2000, pp. 10197-10202. http://dx.doi.org/10.1073/pnas.97.18.10197
 X. Yang, K. K. Sheares, N. Davie, P. D. Upton, G. W. Taylor, J. Horsley, J. Wharton and N. W. Morrell, “Hypoxic Induction of Cox-2 Regulates Proliferation of Human Pulmonary Artery Smooth Muscle Cells,” American Journal of Respiratory Cell and Molecular Biology, Vol. 27, No. 6, 2002, pp. 688-696.
 R. Bolli, K. Shinmura, X. L. Tang, E. Kodani, Y. T. Xuan, Y. Guo and B. Dawn, “Discovery of a New Function of Cyclooxygenase (COX)-2: COX-2 Is a Cardioprotective Protein That Alleviates Ischemia/Reperfusion Injury and Mediates the Late Phase of Preconditioning,” Cardiovascular Research, Vol. 55, No. 3, 2002, pp. 506-519.
 G. Wu G, A. P. Mannam, J. Wu, S. Kirbis, J. L. Shie, C. Chen, R. J. Laham, F. W. Sellke and J. Li, “Hypoxia Induces Myocyte-Dependent COX-2 Regulation in Endothelial Cells: Role of VEGF,” American Journal of Physiology Heart Circulation Physiology, Vol. 285, No. 6, 2003, pp. H2420-H2429.
 L. Sterin-Borda, P. M. Cossio, M. F. Gimeno, A. L. Gimeno, C. Diez, R. P. Laguens, P. C. Meckert and R. M. Arana, “Effect of Chagasic Sera on the Rat Isolated Atrial Preparation: Immunological, Morphological and Function Aspects,” Cardiovascular Research, Vol. 10, No. 6, 1976, pp. 613-622. http://dx.doi.org/10.1093/cvr/10.6.613
 P. Zong, S. Setty, W. Sun, R. Martinez, J. D. Tune, I. V. Ehrenbourg, E. N. Tkatchouk, R. T. Mallet and H. F. Downey, “Intermittent Hypoxic Training Protects Canine Myocardium from Infarction,” Experimental Biology and Medicine (Maywood, N.J.), Vol. 229, No. 8, 2004, pp. 806-812.
 B. Zamorano, “Subcellular Localization of Prostaglandin-E3 in Rat Heart Tissue,” Cardiovascular Drugs & Therapeutics, Vol. 5, No. 3, 1991, pp. 655-657.
 H. A. Peredo, E. J. Filinger, S. Sanguinetti, P. S. Lorenzo and E. Adler-Graschinsky, “Prostanoid Production in Hypoxic Rat Isolated Atria: Influence of Acute Diabetes,” Prostaglandins Leukot Essent Fatty Acids, Vol. 51, No. 4, 1994, pp. 231-234.
 R. Rösen, P. Rösen, R. Ohlendorf and K. Schrör, “Prostacyclin Prevents Ischemia-Induced Increase of Lactate and Cyclic AMP in Ischemic Myocardium,” European Journal of Pharmacology, Vol. 69, No. 4, 1981, pp. 489-491. http://dx.doi.org/10.1016/0014-2999(81)90454-4
 S. C. Wong, M. Fukuchi, P. Melnyk, I. Rodger and A. Giaid, “Induction of Ciclooxygenase 2 and Activation of Nuclear Factor-kappa B in Myocardium of Patients with Congestive Heart Failure,” Circulation, Vol. 98, No. 2, 1998, pp. 100-103.